Physion's ElectroMotive Drug Administration technology offers a comprehensive and innovative treatment program for urinary bladder diseases.
NON-MUSCLE INVASIVE BLADDER CANCER
EMDA® Electromotive Drug Administration is a minimally invasive method of enhancing local drug penetration across the urothelium of the bladder and prostatic urethra, resulting in greater quantities of local drug being delivered to a greater tissue depth than is achievable by passive diffusion alone, allowing a better clinical efficacy. EMDA® treatment helps avoid many side effects often associated with systemic administration.
TREATMENT OF BLADDER DISEASES IN AN OUTPATIENT SETTING
EMDA® (Electro-Motive Drug Administration) system for painless administration of anti-inflammatory drug dexamethasone and anti-collagen verapamil in the plaques
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.